HEC
Hudson Executive Capital Portfolio holdings
AUM
$135M
This Quarter Return
+10.99%
1 Year Return
+30.05%
3 Year Return
+142.48%
5 Year Return
+146.32%
10 Year Return
–
AUM
$218M
AUM Growth
+$218M
(-15%)
Cap. Flow
-$59.1M
Cap. Flow
% of AUM
-27.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
1
Closed
2
Top Buys
| 1 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$15.2M |
| 2 |
VIVO
Meridian Bioscience Inc
VIVO
|
$1.94M |
Top Sells
| 1 |
CCMP
CMC Materials, Inc. Common Stock
CCMP
|
$44.8M |
| 2 |
KATE
Kate Spade & Company
KATE
|
$24.1M |
| 3 |
CIT
CIT Group Inc.
CIT
|
$7.31M |
Sector Composition
| 1 | Healthcare | 76.03% |
| 2 | Financials | 23.97% |
| 3 | Consumer Discretionary | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $75M | 34.47% |
950,600
| – | – |
|
|
CIT
2
DELISTED
CIT Group Inc.
CIT
| $52.2M | 23.97% |
1,070,857
-150,000
| -12% | -$7.31M |
|
3
AtriCure
ATRC
$1.84B
| $45M | 20.67% |
1,855,000
| – | – |
|
|
CVRS
4
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $21.1M | 9.69% |
11,336,154
| – | – |
|
|
ACOR
5
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $15.2M | 7% |
+773,090
| New | +$15.2M |
|
|
MGLN
6
DELISTED
Magellan Health Services, Inc.
MGLN
| $7.2M | 3.31% |
98,700
| – | – |
|
|
VIVO
7
DELISTED
Meridian Bioscience Inc
VIVO
| $1.94M | 0.89% |
+123,300
| New | +$1.94M |
|
8
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
|
CCMP
9
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| – | – |
-585,300
| Closed | -$44.8M |
|
|
KATE
10
DELISTED
Kate Spade & Company
KATE
| – | – |
-1,039,000
| Closed | -$24.1M |
|